Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

IRD holding history

Opus Genetics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IRD overviewAll 13F holders of IRDFull Q2 2026 holdings

Shares (Q2 2026)
683,895
Value
$2.81M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of IRD by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026683,895$2.81M<0.1%+426,246+165.4%AddedHolders
Q1 2026257,649$1.17M<0.1%+167,831+186.9%AddedHolders
Q4 202589,818$180.5K<0.1%+88,934+10,060.4%AddedHolders
Q3 2025884$1.46K<0.1%−27,226−96.9%ReducedHolders
Q2 202528,110$26.5K<0.1%−11,854−29.7%ReducedHolders
Q1 202539,964$39.2K<0.1%+7,273+22.2%AddedHolders
Q4 202432,691$38.9K<0.1%+27,004+474.8%AddedHolders
Q3 20245,687$7.45K<0.1%−10,016−63.8%ReducedHolders
Q2 202415,703$24.0K<0.1%+1,475+10.4%AddedHolders
Q1 202414,228$28.6K<0.1%+8,830+163.6%AddedHolders
Q4 20235,398$16.2K<0.1%+5,398NewHolders
Q3 20230$00.0%−8,751−100.0%Sold outHolders
Q2 20238,751$38.0K<0.1%+8,187+1,451.6%AddedHolders
Q1 2023564$2.12K<0.1%+564NewHolders
Q4 20220$00.0%−1,700−100.0%Sold outHolders
Q3 20221,700$3.00K<0.1%−766−31.1%ReducedHolders
Q2 20222,466$5.00K<0.1%−3,282−57.1%ReducedHolders
Q1 20225,748$19.0K<0.1%−1,397−19.6%ReducedHolders
Q4 20217,145$27.0K<0.1%−693−8.8%ReducedHolders
Q3 20217,838$41.0K<0.1%+2,296+41.4%AddedHolders
Q2 20215,542$30.0K<0.1%+3,732+206.2%AddedHolders
Q1 20211,810$11.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.